Recombinant Human REG3g Protein，His

REG3g (Regenerating Islet-Derived 3 gamma) is a member of the Reg family of proteins, which are known for their role in the regeneration of pancreatic beta cells and involvement in innate immunity, particularly in the gastrointestinal tract. Emerging research has highlighted REG3g's antimicrobial properties and its potential role in maintaining intestinal homeostasis. Its expression is upregulated in response to intestinal injury and inflammation, suggesting a protective role against pathogen invasion and a regulatory function in gut microbiota. Additionally, REG3g has been implicated in various diseases, including inflammatory bowel disease (IBD) and colorectal cancer, making it a target of interest for therapeutic interventions. Studies indicate that REG3g not only possesses bactericidal activity against a range of pathogens but also plays a crucial role in modulating inflammatory responses. Understanding the mechanisms underlying REG3g's function could provide insights into its potential as a biomarker for gastrointestinal diseases and its utility in developing novel treatment strategies. Researchers are now focusing on elucidating the signaling pathways associated with REG3g and its interactions with gut microbes, aiming to harness its properties for therapeutic applications in gut health and disease management. Overall, the study of REG3g represents a promising avenue for advancing our understanding of intestinal biology and the development of innovative treatments for related disorders.